We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Image of Molly Campbell

Molly Campbell profile page

Senior Science Writer

In the editorial team Molly reports on a broad range of scientific topics, covering the latest breaking news and writing long-form pieces for The Scientific Observer. She is a fervent believer that science – and science communications – should be accessible to everyone. In 2020, she created the Teach Me in 10 video series, where weekly guests discuss and teach a scientific concept in less than 10 minutes. Prior to joining Technology Networks in 2019, Molly worked as a clinical research associate in the NHS and as a freelance science writer. She has a first-class honors degree in neuroscience from the University of Leeds and received a Partnership Award for her efforts in science communication.

Got a Question for Molly Campbell?

Get in touch using the contact form linked here and we’ll get back to you shortly

Published Content
Total: 860
The Power of Proteogenomics in Precision Medicine content piece image

The Power of Proteogenomics in Precision Medicine

Part of the "systems biology" trend, proteogenomics is expanding at an accelerating rate. In this article, we look at the approaches adopted in proteogenomics and explore how proteogenomics is changing the dynamics of precision medicine in oncology.
Industry Insight

Calculating Gestational Age With Metabolomics

Researchers have developed a mathematical model that may offer an alternative to relying on ultrasound information for calculating gestational age. The model, utilizing a "metabolomic fingerprint" approach, may overcome barriers in preterm death research.

A Potential Role for Sperm in Repeat Miscarriages

In a new study, researchers analyze the potential role that sperm DNA damage may have in recurrent pregnancy loss.
Industry Insight

Proteomics Experts Unite for EPIC-XS

The European Proteomics Infrastructure Consortium providing access (EPIC-XS) consists of a network of experienced research groups that share one common goal: to facilitate the development and sustainability of proteomics explorations to researchers within the European Union. We spoke with Martina O’Flaherty from the EPIC-XS project office to learn more.
Industry Insight

“Mastermind” Scientists Help Diagnose Rare Diseases

The Rare Genomics Institute announced on Rare Disease Day 2019 that they had used the Mastermind Genomic Search Engine, a clinical decision support tool by Genomenon, to diagnose a rare disease patient. We spoke to Mark Kiel, MD, PhD, Founder and Chief Science Officer at Genomenon and Romina Ortiz, COO at the Rare Genomics Institute, to learn more about the application of this technology in rare diseases.

Exploring the Genetics of Sleep

In this article, we explore the scientific research that looks at the links between our genes, why we sleep, and the negative impact a lack of sleep may have.
Industry Insight

Tiny Protein Has Huge Potential in CRISPR

Last year the smallest CRISPR protein, Cas14 was discovered. We spoke to the scientists that made the discovery, Lucas Harrington, at Mammoth Biosciences, to learn more about Cas14.

Common Anti-fungal Drug Considered for Use in Cystic Fibrosis

Cystic fibrosis (CF) is a devastating genetic disorder for which no cure is available. Researchers have explored the impact of a widely used anti-fungal drug that is already available on the market in CF models - with promising results.
Industry Insight

Automated Microfluidic Systems for Gene Editing

Recently, Oxford Genetics and Sphere Fluidics announced a multi-partner collaboration to expedite the development of automated microfluidic systems for rapid and high-throughput gene editing in mammalian cells. We spoke with Emily Leproust, PhD, CEO of Twist Biosciences, and other collaborators from the partnership to discuss the background of this announcement and the need for automated systems in gene editing.

Genetics May Help Us Save the Bees

The use of pesticides is causing a decline in the global bee population. In a study, researchers have looked at the molecular impact pesticides have on gene expression in the bumblebee.